Artixio

Regulatory Services for Veterinary Products in South Korea

Complete End-to-End support for Veterinary Products in South Korea

Artixio is a leading global regulatory consulting company providing the clients with effective strategies and integrated solutions to successfully register and commercialize a product in South Korea market. With a presence in over 120+ countries, we provide complete support throughout the lifecycle of a product.

Veterinary industry in South Korea

In the South Korea, Animal drug industry is an industry of high added values that is expected to show consistent growth. According to the Pharmaceutical Affairs Act and the special provisions under Medical Devices Act, animal drugs and animal medical devices are controlled under the Ministry of Agriculture, Food and Rural Affairs (MAFRA).
Animal medicine in South Korea refers to drugs used only for animals; and it also includes raising bees, silkworm, fishery and pets (including aquarium pets).
The MAFRA operates the laws while the Animal and Plant Quarantine Agency (APQA) gives manufacturing and importing permits, quality control and licensing of Veterinary Medicinal Products and manages safety such as setting up standards, and local governments manage distribution and sales.
The MAFRA or the Minister of Oceans and Fisheries may determine standards for use, such as animals for which such drugs are used, dose regimen, dose, and the period for prohibiting its use.

Artixio provides

Why Artixio?

Regional expertise
Well collaborated with Health Authorities
Global presence
Client focused services
Experts team with experience in successful product commercialization
Strategies to reduce the market entry time of product
ISO 9001:2015 Certified Company

FAQs

What is the Positive List System (PLS) for Veterinary drugs in South Korea?
It is the system introduced to facilitate safety management for veterinary drugs. Under the PLS the uniform limit (0.01mg/kg) applies to domestic and imported livestock and fishery products for which the Maximum Residual Limit (MRL) is not set in Korea. It prevents the import in cases where the safety of veterinary drugs has not been proven.
Our team provides post approval services to ensure ongoing compliance with the regulations of South Korea including Annual Maintenance, License Renewals, Variation submissions, Labelling updates, ADR reporting, Audit and Inspections support with legal representative agent services.
Yes, we provide Quality Management Services (QMS) to comply with the regulatory requirements of South Korea.
Our Quality Management Services include
  • Quality System Assessment & Compliance
    • Audit support
    • GMP (Good Manufacturing Practice)
    • GCP (Good Clinical Practice)
    • GPVP (Good Pharmacovigilance Practice)
    • Gap Analysis
    • 3rd Party Analysis
    • Quality System Development
    • GXP Training
  • GXP Consultation and Support Service
  • Operations & Routine QA Support
    • SOP Authoring, Review & Harmonization
    • CAPA (Corrective and Preventive Actions)
    • PQR (Product Quality Review)
    • Change Management

Regulatory Expertise Across
Multiple Countries

India
Vietnam
Mexico​
Vietnam
United States
Brazil
Europe
Malaysia
Taiwan
China
Thailand
Philippines

Industries we serve

Pharmaceuticals

Cosmetics

Nutrition

Medtech

Biologics

Veterinary

Blogs

In Vitro Diagnostics: Meaning, Types And Benefits

In Vitro Diagnostics: Meaning,

The term “in vitro” is a Latin word that means “in glass”. Thus, from...

June 20, 2025
IVD Medical Devices Registration & Approval In India

IVD Medical Devices Registration

The in vitro diagnostic in India is regulated by the Central Drugs Standard Control...

June 17, 2025
Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Once overlooked pharma hub in Mexico's Hidalgo region has gained importance with global market...

June 18, 2025